Short-term treatment with nitrous oxide has shown promise for treating depressive disorders. | Drug Discovery And Development ...
Patients with major depressive disorder, including those who have not responded to first-line antidepressants, may benefit from short-term nitrous oxide treatment, a major meta-analysis led by the ...
Laughing gas (nitrous oxide) appears to offer rapid mood improvement for people with severe or treatment-resistant depression ...
The U.S. Food and Drug Administration (FDA) on Thursday approved the medication Exxua to treat major depressive disorder – a significant step after a decades-long battle for approval. Exxua is unique ...
Researchers have identified a specific structural change in the brain that appears to track with the relief of depressive ...
Spravato (esketamine) is a nasal spray used for depression and was approved by the FDA in 2019. It is specifically for treatment-resistant depression, meaning depression symptoms that have not gotten ...
News-Medical.Net on MSN
Extra sleep after the autumn clock change linked to reduced demand for NHS health services
The week after the autumn clock change is associated with a reduction in demand for NHS services for sleep disorders, ...
More than two million Americans age 65 and older suffer from depression, but research says almost 80 percent don't receive adequate help for this serious, but treatable disorder. Seniors tend to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results